Home > Journals > Minerva Chirurgica > Past Issues > Minerva Chirurgica 2010 December;65(6) > Minerva Chirurgica 2010 December;65(6):635-54

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA CHIRURGICA

A Journal on Surgery


Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,877


eTOC

 

REVIEWS  QUESTIONS AND CONTROVERSIES IN SURGERY IN 2010


Minerva Chirurgica 2010 December;65(6):635-54

language: English

Endoluminal management of bronchogenic carcinoma in 2010: diagnosis, staging, and therapy

Horne Z. D., Landreneau R. J., Luketich J. D., Schuchert M. J.

Division of Thoracic Surgery, Heart, Lung and Esophageal Surgery Institute, University of Pittsburgh Medical Center
Pittsburgh, PA, USA


PDF  


Endoluminal bronchogenic carcinoma, though a minority of lung cancer cases, presents a unique opportunity to utilize techniques for the diagnosis and therapy that are unavailable for more peripheral tumors. This review explores current techniques for the diagnosis, staging, and therapy of endoluminal central bronchogenic tumors and also introduces techniques currently under investigation as potential improvements or replacements for current techniques using recent literature. Additionally, the new staging criteria set forth in the 7th edition of the TMN staging system as a result of the American Joint Committee on Cancer (AJCC), International Union Against Cancer (IUCC), and the International Association for the Study of Lung Cancer (IASLC) are discussed with respect to endoluminal bronchogenic carcinoma.

top of page

Publication History

Cite this article as

Corresponding author e-mail

hornezd@gmail.com